Cytokine and growth factor profiling in patients with the metabolic syndrome

British Journal of Nutrition

Volumn 113, Issue 12, 2015, Pages 1911-1919

  Mirhafez, Seyed Reza ^a,b   Pasdar, Alireza ^b,c   Avan, Amir ^b   Esmaily, Habibollah ^b   Moezzi, Atefeh ^d   Mohebati, Mohsen ^d   Meshkat, Zahra ^b   Mehrad Majd, Hassan ^a   Eslami, Saied ^b,e   Rahimi, Hamid Reza ^b   Ghazavi, Hamed ^b   Ferns, Gordon A ^f   Ghayour Mobarhan, Majid ^b,d  

^a NEYSHABUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

Author keywords

Cytokines; Diabetes; Growth factors; Inflammation; Metabolic syndrome

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; CYTOKINE; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; GLUCOSE; GROWTH FACTOR; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCYTE CHEMOTACTIC PROTEIN 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; CCL2 PROTEIN, HUMAN; GLUCOSE BLOOD LEVEL; GROWTH PROMOTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN DERIVATIVE; VASCULOTROPIN A;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HIP CIRCUMFERENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PROTEIN BLOOD LEVEL; WAIST CIRCUMFERENCE; ABDOMINAL OBESITY; ANALYSIS; BLOOD; BLOOD PRESSURE; COMPLICATION; DIET RESTRICTION; MIDDLE AGED;

BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHEMOKINE CCL2; CHOLESTEROL, HDL; CYTOKINES; EPIDERMAL GROWTH FACTOR; FASTING; FEMALE; GROWTH SUBSTANCES; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-1ALPHA; INTERLEUKINS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, ABDOMINAL; TRIGLYCERIDES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WAIST CIRCUMFERENCE;

EID: 84936891331     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114515001038     Document Type: Article

References (45)

1. Grundy SM, Cleeman JI, Daniels SR, et al. (2006) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol 21, 1-6.
2. Isomaa B, Almgren P, Tuomi T, et al. (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24, 683-689.
3. Lakka HM, Laaksonen DE, Lakka TA, et al. (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288, 2709-2716.
4. Girman CJ, Rhodes T, Mercuri M, et al. (2004) The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol 93, 136-141.
5. Malik S, Wong ND, Franklin SS, et al. (2004) Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110, 1245-1250.
6. Grundy SM, Hansen B, Smith SC, et al. (2004) Clinical management of metabolic syndrome report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 109, 551-556.
7. Sutherland JP, McKinley B & Eckel RH (2004) The metabolic syndrome and inflammation. Metab Syndr Relat Disord 2, 82-104.
8. Berg AH & Scherer PE (2005) Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96, 939-949.
9. Frohlich M, Imhof A, Berg G, et al. (2000) Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 23, 1835-1839.
10. Ford ES (2003) The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis 168, 351-358.
11. Edalat B, Sharifi F, Badamchizadeh Z, et al. (2013) Association of metabolic syndrome with inflammatory mediators in women with previous gestational diabetes mellitus. J Diabetes Metab Disord 12,8.
12. Van Exel E, Gussekloo J, de Craen AJ, et al. (2002) Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes: the Leiden 85-Plus Study. Diabetes 51, 1088-1092.
13. Moon YS, Kim DH & Song DK (2004) Serum tumor necrosis factor-alpha levels and components of the metabolic syndrome in obese adolescents. Metabolism 53, 863-867.
14. Yudkin JS, Juhan-Vague I, Hawe E, et al. (2004) Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. Metabolism 53, 852-857.
15. Choi K, Lee J, Lee K, et al. (2004) Comparison of serum concentrations of C-reactive protein, TNF-α, and interleukin 6 between elderly Korean women with normal and impaired glucose tolerance. Diabetes Res Clin Pract 64, 99-106.
16. Salmenniemi U, Ruotsalainen E, Pihlajama¨ki J, et al. (2004) Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation 110, 3842-3848.
17. Matsushita K, Yatsuya H, Tamakoshi K, et al. (2006) Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men. Arterioscler Thromb Vasc Biol 26, 871-876.
18. Kern PA, Ranganathan S, Li C, et al. (2001) Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280, 745-751.
19. Mirhafez SR, Mohebati M, Feiz Disfani MP, et al. (2014) An imbalance in serum concentrations of inflammatory and anti-inflammatory cytokines in hypertension. J Am Soc Hypertens 8, 614-623.
20. Molloy RM, Mc Connell RI, Lamont JV, et al. (2005) Automation of biochip array technology for quality results. Clin Chem Lab Med 43, 1303-1313.
21. Fitzgerald SP, Lamont JV, McConnell RI, et al. (2005) Development of a high-throughput automated analyzer using biochip array technology. Clin Chem 51, 1165-1176.
22. Nepusz T, Yu H & Paccanaro A (2012) Detecting overlapping protein complexes in protein - protein interaction networks. Nat Methods 9, 471-472.
23. Eckel RH, Grundy SM & Zimmet PZ (2005) The metabolic syndrome. Lancet 365, 1415-1428.
24. Fernández Real JM & Ricart W (2003) Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 24, 278-301.
25. Trayhurn P & Wood IS (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92, 347-355.
26. Ridker PM, Buring JE, Cook NR, et al. (2003) C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107, 391-397.
27. Miyazaki Y, Pipek R, Mandarino LJ, et al. (2003) Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients. Int J Obes Relat Metab Disord 27, 88-94.
28. Giulietti A, van Etten E, Overbergh L, et al. (2007) Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res Clin Pract 77, 47-57.
29. Odegaard JI & Chawla A (2012) Connecting type 1 and type 2 diabetes through innate immunity. Cold Spring Harb Perspect Med 2, a007724.
30. Yaturu S, Rains J & Jain SK (2008) Relationship of elevated osteoprotegerin with insulin resistance, CRP, and TNF-alpha levels in men with type 2 diabetes. Cytokine 44, 168-171.
31. Fleischman A, Shoelson SE, Bernier R, et al. (2008) Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care 31, 289-294.
32. Makki N, Thiel KW & Miller FJ (2013) The epidermal growth factor receptor and its ligands in cardiovascular disease. Int J Mol Sci 14, 20597-20613.
33. Azimi-Nezhad M, Stathopoulou MG, Bonnefond A, et al. (2013) Associations of vascular endothelial growth factor (VEGF) with adhesion and inflammation molecules in a healthy population. Cytokine 61, 602-607.
34. Emanuela F, Grazia M, Marco de R, et al. (2012) Inflammation as a link between obesity and metabolic syndrome. J Nutr Metab 2012, 476380.
35. Hotamisligil GS & Erbay E (2008) Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol 8, 923-934.
36. Zhang J & Shi GP (2012) Mast cells and metabolic syndrome. Biochim Biophys Acta 1822, 14-20.
37. Li P, Zhao Y, Wu X, et al. (2012) Interferon gamma (IFN-γ) disrupts energy expenditure and metabolic homeostasis by suppressing SIRT1 transcription. Nucleic Acids Res 40, 1609-1620.
38. Um JY, Rim HK, Kim SJ, et al. (2012) Functional polymorphism of IL-1 alpha and its potential role in obesity in humans and mice. PLOS ONE 6, e29524.
39. Mehra VC, Ramgolam VS & Bender JR (2005) Cytokines and cardiovascular disease. J Leukoc Biol 78, 805-818.
40. Fearon WF & Fearon DT (2008) Inflammation and cardiovascular disease: role of the interleukin-1 receptor antagonist. Circulation 117, 2577-2579.
41. Li L, Wang L, Wu Z, et al. (2014) Anthocyanin-rich fractions from red raspberries attenuate inflammation in both RAW264.7 macrophages and a mouse model of colitis. Sci Rep 4, 6234.
42. Zhou A, Scoggin S, Gaynor RB, et al. (2003) Identification of NF-κB-regulated genes induced by TNFα utilizing expression profiling and RNA interference. Oncogene 22, 2054-2064.
43. Blagosklonny MV (2013) TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists. Cell Death Dis 4, e964.
44. Nazeminezhad R, Tajfard M, Latiff LA, et al. (2014) Dietary intake of patients with angiographically defined coronary artery disease and that of healthy controls in Iran. Eur J Clin Nutr 68, 109-113.
45. Jungbauer A & Medjakovic S (2012) Anti-inflammatory properties of culinary herbs and spices that ameliorate the effects of metabolic syndrome. Maturitas 71, 227-239.